2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Schmitt Daniel M | — | 544,111 | Aug 14, 2024 |
| Lytle Paul J | — | 234,971 | Aug 14, 2024 |
| BP Directors, LP | Director | 131,248 | Aug 20, 2024 |
| Bios Equity COF, LP | Director | 131,248 | Aug 20, 2024 |
| Bios Clinical Opportunity Fund, LP | Director | 131,248 | Aug 20, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 13, 2026 | SCHMITT DANIEL M | CEO | Sell | 40.0 | -121,874 | -13.50% | ✗ | $527.7K |
| Jan 5, 2026 | Jan 7, 2026 | THOMSON TODD S | Director | Sell | 17.5 | -280,000 | -10.63% | ✗ | $1.6M |
| Jun 27, 2025 | Jun 30, 2025 | Bios Equity COF, LP | Director | Buy | 75.0 | +71,428 | 0.71% | ✗ | $500K |
| Jun 27, 2025 | Jun 30, 2025 | Kreis Leslie W. | Director | Buy | 75.0 | +71,428 | 0.71% | ✗ | $500K |
| Jun 27, 2025 | Jun 30, 2025 | Fletcher Aaron G.L. | Director | Buy | 75.0 | +71,428 | 0.71% | ✗ | $500K |
| May 22, 2025 | May 23, 2025 | THOMSON TODD S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 22, 2025 | May 23, 2025 | Sawhney Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 22, 2025 | May 23, 2025 | Zabrowski Dan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 22, 2025 | May 23, 2025 | Fletcher Aaron G.L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 22, 2025 | May 23, 2025 | Keyes Jason A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 22, 2025 | May 23, 2025 | RONNEBERG AMY L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2025 | Apr 2, 2025 | SCHMITT DANIEL M | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2025 | Apr 2, 2025 | Mazar Andrew Paul | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2025 | Apr 2, 2025 | LYTLE PAUL J | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 14, 2024 | Aug 20, 2024 | Bios Equity COF, LP | Director | Sell | 22.5 | -24,999 | -1.74% | ✗ | $200K |
| Aug 14, 2024 | Aug 20, 2024 | Fletcher Aaron G.L. | Director | Sell | 22.5 | -24,999 | -1.74% | ✗ | $200K |
| Aug 14, 2024 | Aug 20, 2024 | Kreis Leslie W. | 10% Owner | Sell | 22.5 | -24,999 | -1.74% | ✗ | $200K |
| Aug 14, 2024 | Aug 16, 2024 | THOMSON TODD S | Director | Sell | 22.5 | -18,750 | -1.56% | ✗ | $150K |
| Aug 14, 2024 | Bios Equity COF, LP | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 14, 2024 | Aug 14, 2024 | Bios Equity COF, LP | Director | Buy | 100.0 | +475,001 | 20.46% | ✗ | $3.8M |
| Aug 14, 2024 | Fletcher Aaron G.L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 14, 2024 | Aug 14, 2024 | Fletcher Aaron G.L. | Director | Buy | 100.0 | +475,001 | 20.46% | ✗ | $3.8M |
| Aug 14, 2024 | Kreis Leslie W. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 14, 2024 | Aug 14, 2024 | Kreis Leslie W. | 10% Owner | Buy | 100.0 | +475,001 | 20.46% | ✗ | $3.8M |
| Aug 14, 2024 | Bios 2024 Co-Invest, LP | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 12, 2024 | Aug 14, 2024 | Zabrowski Dan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 14, 2024 | Aug 14, 2024 | SCHMITT DANIEL M | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 14, 2024 | Aug 14, 2024 | LYTLE PAUL J | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 12, 2024 | Aug 14, 2024 | Keyes Jason A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 12, 2024 | Aug 14, 2024 | RONNEBERG AMY L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 12, 2024 | Aug 14, 2024 | Sawhney Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 14, 2024 | RONNEBERG AMY L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 14, 2024 | Sawhney Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 12, 2024 | Zabrowski Dan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 12, 2024 | SCHMITT DANIEL M | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 12, 2024 | Mazar Andrew Paul | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 12, 2024 | LYTLE PAUL J | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 12, 2024 | Keyes Jason A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 12, 2024 | THOMSON TODD S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 12, 2024 | Bios Clinical Opportunity Fund, LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 12, 2024 | Fletcher Aaron G.L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 12, 2024 | Kreis Leslie W. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |